T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Banco Santander Chile
BSAC
$12.1B
| $7.23M | ﹤0.01% |
370,950
-3,858,418
| -91% | -$75.2M |
|
1152
Ovintiv
OVV
$10.8B
| $7.19M | ﹤0.01% |
163,690
+8,238
| +5% | +$362K |
|
1153
United Therapeutics
UTHR
$18.3B
| $7.05M | ﹤0.01% |
32,045
+7,704
| +32% | +$1.69M |
|
1154
Timken Company
TKR
$5.4B
| $7.03M | ﹤0.01% |
87,650
+2,200
| +3% | +$176K |
|
1155
Alamo Group
ALG
$2.49B
| $6.98M | ﹤0.01% |
33,214
+2,060
| +7% | +$433K |
|
1156
US Foods
USFD
$17.9B
| $6.93M | ﹤0.01% |
152,476
+8,698
| +6% | +$395K |
|
1157
WSFS Financial
WSFS
$3.13B
| $6.83M | ﹤0.01% |
148,693
+25,222
| +20% | +$1.16M |
|
1158
Essent Group
ESNT
$6.29B
| $6.74M | ﹤0.01% |
127,734
+32,186
| +34% | +$1.7M |
|
1159
Insight Enterprises
NSIT
$3.9B
| $6.57M | ﹤0.01% |
37,063
+18,329
| +98% | +$3.25M |
|
|
EVRI
1160
DELISTED
Everi Holdings
EVRI
| $6.56M | ﹤0.01% |
582,198
-337,033
| -37% | -$3.8M |
|
1161
BioNTech
BNTX
$23.3B
| $6.56M | ﹤0.01% |
62,157
+1,544
| +3% | +$163K |
|
1162
HEICO Class A
HEI.A
$34.9B
| $6.36M | ﹤0.01% |
44,619
+3,474
| +8% | +$495K |
|
1163
Roku
ROKU
$13.9B
| $6.24M | ﹤0.01% |
68,070
+6,395
| +10% | +$586K |
|
1164
Cognex
CGNX
$7.45B
| $6.22M | ﹤0.01% |
149,046
+5,760
| +4% | +$240K |
|
1165
Old Republic International
ORI
$10B
| $6.18M | ﹤0.01% |
210,254
+12,916
| +7% | +$380K |
|
1166
Ally Financial
ALLY
$13B
| $6.14M | ﹤0.01% |
175,829
-17,864
| -9% | -$624K |
|
1167
Genmab
GMAB
$17.1B
| $6.03M | ﹤0.01% |
189,491
-11,227
| -6% | -$358K |
|
1168
Oric Pharmaceuticals
ORIC
$1.05B
| $6M | ﹤0.01% |
651,561
+606,446
| +1,344% | +$5.58M |
|
1169
Sprouts Farmers Market
SFM
$13.3B
| $5.98M | ﹤0.01% |
124,191
-10,212
| -8% | -$491K |
|
1170
Brixmor Property Group
BRX
$8.57B
| $5.97M | ﹤0.01% |
256,718
+12,208
| +5% | +$284K |
|
1171
Jazz Pharmaceuticals
JAZZ
$7.65B
| $5.95M | ﹤0.01% |
48,344
+18,796
| +64% | +$2.31M |
|
1172
Westlake Corp
WLK
$11.3B
| $5.92M | ﹤0.01% |
42,297
+109
| +0.3% | +$15.3K |
|
1173
Ginkgo Bioworks
DNA
$593M
| $5.86M | ﹤0.01% |
86,678
+500
| +0.6% | +$33.8K |
|
1174
Aura Biosciences
AURA
$384M
| $5.85M | ﹤0.01% |
659,692
+2,663
| +0.4% | +$23.6K |
|
1175
NorthWestern Energy
NWE
$3.51B
| $5.84M | ﹤0.01% |
114,729
-1,513
| -1% | -$77K |
|